Axogen AXGN

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
-$0.04 (-0.23%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0

Relative Strength Index (RSI)

- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

- The RSI is calculated using the following formula:

RSI = 100 - (100 / (1 + RS))

Where RS is the ratio of the average gains to the average losses over a specified period.

- The default time period used is 14 days.

- RSI values range between 0 and 100.

RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

About

Business overview of Axogen (AXGN)
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.

Key Insights

Critical company metrics and information

  • Latest Closing Price

    $17.73

  • Market Cap

    $786.22 Million

  • Price-Earnings Ratio

    -77.09

  • Total Outstanding Shares

    44.01 Million Shares

  • Total Employees

    452

  • Dividend

    No dividend

  • IPO Date

    December 17, 1986

  • SIC Description

    Electromedical & Electrotherapeutic Apparatus

  • Primary Exchange

    NASDAQ

  • Type

    Common Stock

  • Headquarters

    13631 progress blvd., Alachua, FL, 32615

  • Homepage

    https://www.axogeninc.com

Historical Stock Splits

Execution DateSplit Amount
No Historical Stock Splits

Cash Flow Statement

January 1, 2024 to December 31, 2024
MetricValue
Net Cash Flow$-3.47 Million
Net Cash Flow From Operating Activities$4.54 Million
Net Cash Flow From Financing Activities$2.29 Million
Net Cash Flow From Investing Activities, Continuing$-10.30 Million
Net Cash Flow From Investing Activities$-10.30 Million
Net Cash Flow From Financing Activities, Continuing$2.29 Million

Income Statement

January 1, 2024 to December 31, 2024
MetricValue
Cost Of Revenue$45.36 Million
Revenues$187.34 Million
Diluted Average Shares$44.26 Million
Basic Earnings Per Share$-0.23
Operating Income/Loss$-3.29 Million
Net Income/Loss$-9.96 Million

Comprehensive Income

January 1, 2024 to December 31, 2024
MetricValue
Comprehensive Income/Loss$-9.96 Million
Comprehensive Income/Loss Attributable To Noncontrolling Interest$0
Other Comprehensive Income/Loss$0
Comprehensive Income/Loss Attributable To Parent$-9.96 Million

Balance Sheet

January 1, 2024 to December 31, 2024
MetricValue
Other Current Liabilities$22.60 Million
Noncurrent Assets$104.51 Million
Current Assets$99.22 Million
Liabilities$99.82 Million
Liabilities And Equity$203.73 Million
Current Liabilities$30.61 Million

Historical Dividends

Announcement DatePayment DateRecord DateAmountFrequency
No historical dividends

Recent Headlines From The Web

Latest news, press releases, and media coverage about AXGN from trusted financial sources
    All TickersEarnings CalendarNews ArticlesAbout UsPrivacy & Cookies Info

    ⓒ 2025 Financhle. All Rights Reserved.